A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman’s Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment

Table 2

Principal laboratory and clinical parameters of the patient before and after TCZ treatment.

	Baseline	4th month	12th month	24th month	36th month
PCR (mg/l)	8.5	1	1	1	1
VES (mm/1h)	48	12	11	15	13
DAS28	4.25	1.7	1.5	1.8	1.2
SDAI	27.85	4.1	3.3	3.2	2.9
CDAI	27	4	3.2	3.1	2.8
HAQ	2.125	1	0.75	0.75	0.75